Annual CFO
-$21.05 M
-$7.50 M-55.34%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual cash flow from operations is -$21.05 million, with the most recent change of -$7.50 million (-55.34%) on December 31, 2023.
- During the last 3 years, CNTX annual CFO has fallen by -$20.01 million (-1934.37%).
- CNTX annual CFO is now -1934.37% below its all-time high of -$1.03 million, reached on December 31, 2020.
Performance
CNTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.93 M
+$1.42 M+42.39%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly cash flow from operations is -$1.93 million, with the most recent change of +$1.42 million (+42.39%) on September 1, 2024.
- Over the past year, CNTX quarterly CFO has increased by +$1.42 million (+42.39%).
- CNTX quarterly CFO is now -4334.17% below its all-time high of -$43.60 thousand, reached on September 30, 2021.
Performance
CNTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.88 M
+$1.53 M+8.30%
September 1, 2024
Summary
- As of February 7, 2025, CNTX TTM cash flow from operations is -$16.88 million, with the most recent change of +$1.53 million (+8.30%) on September 1, 2024.
- Over the past year, CNTX TTM CFO has increased by +$1.53 million (+8.30%).
- CNTX TTM CFO is now -8905.82% below its all-time high of -$187.40 thousand, reached on March 31, 2020.
Performance
CNTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CNTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.3% | +42.4% | +8.3% |
| 3 y3 years | -1934.4% | +58.3% | +2.4% |
| 5 y5 years | -642.1% | +58.3% | +2.4% |
CNTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -139.2% | at low | at high | +73.3% | -91.8% | +19.8% |
| 5 y | 5-year | -1934.4% | at low | -4334.2% | +73.3% | -8905.8% | +19.8% |
| alltime | all time | -1934.4% | at low | -4334.2% | +73.3% | -8905.8% | +19.8% |
Context Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.93 M(-42.4%) | -$16.88 M(-8.3%) |
| Jun 2024 | - | -$3.36 M(-23.0%) | -$18.40 M(-6.5%) |
| Mar 2024 | - | -$4.36 M(-39.7%) | -$19.68 M(-6.5%) |
| Dec 2023 | -$21.05 M(+55.3%) | -$7.23 M(+108.8%) | -$21.05 M(+18.6%) |
| Sep 2023 | - | -$3.46 M(-25.3%) | -$17.75 M(+2.7%) |
| Jun 2023 | - | -$4.63 M(-19.2%) | -$17.28 M(+11.8%) |
| Mar 2023 | - | -$5.73 M(+45.8%) | -$15.46 M(+14.1%) |
| Dec 2022 | -$13.55 M | -$3.93 M(+31.2%) | -$13.55 M(-7.1%) |
| Sep 2022 | - | -$2.99 M(+6.7%) | -$14.58 M(+25.4%) |
| Jun 2022 | - | -$2.81 M(-26.6%) | -$11.63 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.82 M(-23.0%) | -$10.90 M(+23.9%) |
| Dec 2021 | -$8.80 M(+750.5%) | -$4.96 M(>+9900.0%) | -$8.80 M(+119.2%) |
| Sep 2021 | - | -$43.60 K(-97.9%) | -$4.01 M(-7.1%) |
| Jun 2021 | - | -$2.08 M(+21.2%) | -$4.32 M(+68.6%) |
| Mar 2021 | - | -$1.72 M(+874.6%) | -$2.56 M(+147.7%) |
| Dec 2020 | -$1.03 M(-63.5%) | -$176.00 K(-49.7%) | -$1.03 M(+20.5%) |
| Sep 2020 | - | -$350.20 K(+9.1%) | -$858.60 K(+68.9%) |
| Jun 2020 | - | -$321.00 K(+71.3%) | -$508.40 K(+171.3%) |
| Mar 2020 | - | -$187.40 K | -$187.40 K |
| Dec 2019 | -$2.84 M | - | - |
FAQ
- What is Context Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Context Therapeutics?
- What is Context Therapeutics annual CFO year-on-year change?
- What is Context Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Context Therapeutics?
- What is Context Therapeutics quarterly CFO year-on-year change?
- What is Context Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Context Therapeutics?
- What is Context Therapeutics TTM CFO year-on-year change?
What is Context Therapeutics annual cash flow from operations?
The current annual CFO of CNTX is -$21.05 M
What is the all time high annual CFO for Context Therapeutics?
Context Therapeutics all-time high annual cash flow from operations is -$1.03 M
What is Context Therapeutics annual CFO year-on-year change?
Over the past year, CNTX annual cash flow from operations has changed by -$7.50 M (-55.34%)
What is Context Therapeutics quarterly cash flow from operations?
The current quarterly CFO of CNTX is -$1.93 M
What is the all time high quarterly CFO for Context Therapeutics?
Context Therapeutics all-time high quarterly cash flow from operations is -$43.60 K
What is Context Therapeutics quarterly CFO year-on-year change?
Over the past year, CNTX quarterly cash flow from operations has changed by +$1.42 M (+42.39%)
What is Context Therapeutics TTM cash flow from operations?
The current TTM CFO of CNTX is -$16.88 M
What is the all time high TTM CFO for Context Therapeutics?
Context Therapeutics all-time high TTM cash flow from operations is -$187.40 K
What is Context Therapeutics TTM CFO year-on-year change?
Over the past year, CNTX TTM cash flow from operations has changed by +$1.53 M (+8.30%)